Maintenance olaparib after platinum-based chemotherapy in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: efficacy by the timing of surgery and residual tumour status following upfront or interval cytoreductive surgery in the Phase III SOLO1 trial

Kathleen N. Moore, Paul DiSilvestro, Giovanni Scambia et al.|International Journal of Gynecological Cancer|2019

Cited by 2